The global market for stereotactic devices was valued at $305 million in 2022 and is projected to grow at a CAGR of 4.3% during the forecast period, reaching $413 million. The full report suite on the global stereotactic device market comprises stereotactic devices.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL STEREOTACTIC DEVICE MARKET INSIGHTS
The economic benefits of using stereotactic devices is one of the main drivers in the market. The use of navigation systems during surgeries results in shorter recovery times for patients and lowers the chances of revision surgery, thereby reducing costs for healthcare facilities.GLOBAL STEREOTACTIC DEVICE MARKET SHARE INSIGHTS
Within the global market for stereotactic devices, there are three key market players - Medtronic, Brainlab, and Stryker. In 2022, Medtronic was the leader in the global stereotactic device market. The company competes with its StealthStation® series.MARKET SEGMENTATION SUMMARY
- Global Stereotactic Device Market
RESEARCH SCOPE SUMMARY
- Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
- Base Year: 2022
- Forecast: 2023-2029
- Historical Data: 2019-2022
- Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
- Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
- Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.
Table of Contents
- Stereotactic Device Market
- Executive Summary
- Global Stereotactic Market Overview
- Competitive Analysis
- Regions Included
- Introduction
- Market Analysis and Forecast
- Drivers and Limiters
- Market Drivers
- Market Limiters
- Competitive Market Share Analysis
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic
- Brainlab
- Stryker
- Elekta
- Integra LifeSciences
- Inomed
- Mizuho
- MRC Systems
- Accuracy
- Adeor Medical
- ANT Neuro
- FHC
- Varian
- Siemens
